This article is about some companies that grow and sell cannabis, a plant that some people use to feel relaxed or happy. The writer is telling us which of these companies are doing well and might make more money soon. They want us to know this so we can maybe buy their stocks and make money too if they keep growing. Read from source...

1. The article is heavily promoting cannabis stocks as a lucrative investment opportunity, but it does not provide any evidence or data to support this claim. It relies on anecdotal examples of some companies that have performed well in the past, but this does not imply that the same trend will continue in the future.
2. The article uses emotional language and appeals to fear of missing out (FOMO) to persuade readers to buy cannabis stocks. For example, it says "Don't make that mistake again" and "chomping at the bit to share these ticker symbols with you ASAP". This is not a rational or objective way of presenting information.
3. The article mentions Michael Berger as an in-house canna stock expert, but it does not provide any credentials or qualifications for him. It also does not disclose any potential conflicts of interest that he may have with the companies he recommends. This creates a lack of trust and credibility for the author and the source.
4. The article does not consider any possible risks or drawbacks associated with investing in cannabis stocks, such as regulatory uncertainties, competition, market volatility, etc. It only focuses on the positive aspects and potential gains, which is a one-sided and biased perspective.

- Cannabix Technologies (OTC:BLOZF): Positive, high growth potential, but also high risk due to OTC listing and lack of revenue. Recommendation: Buy with caution, set a stop loss at 10% below the entry price, and diversify with other cannabis stocks.
- Australis Capital (OTC:AUSAF): Negative, poor performance, low valuation, high debt, and regulatory issues. Recommendation: Sell or avoid, look for better opportunities in the sector.